RhoVac AB announced on April 25, 2019 that Anders Månsson will take up his position as CBO and Deputy CEO already in May, a month earlier than previously announced. As previously announced, RhoVac has appointed Anders Månsson as Chief Business Officer and Deputy CEO as of June 2019. Anders is approaching the end of his current operational assignments, which has led his to be able to start his position in RhoVac already in May, that is one month earlier than expected. Anders has a long and solid experience from the pharmaceutical world both internationally and locally. He has worked in senior positions in major pharmaceutical companies in Sweden, Denmark, UK and Switzerland. In recent years, Anders has also held a number of board positions in biotech /life science in southern Sweden. He has also held a CEO position in a stem cell company in Lund.